Patent ID: 11945803
Assignee: TOSK, INC.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C | IPC C

Claim 3:
4. The pharmaceutical composition according to claim 2, wherein the compound has a structure corresponding to the formula:, wherein:
CL11 is selected from hydrogen, halogen, —CN, —NO2, —OH, —ORa, —C(O)Ra, —CO2Ra, —O(CO)Ra, —C(O)NRaRb, —OC(O)NRaRb, —SRa, —SORa, —SO2Ra, —SO2NRaRb, —NRaRb, —NRaC(O)Rb, —NRaC(O)2Rb, —NRaSO2Rb, —NRa(CO)NRbRc, unsubstituted or substituted C1-8 alkyl, unsubstituted or substituted C2-8 alkenyl, unsubstituted or substituted C2-8 alkynyl, unsubstituted or substituted C3-8 cycloalkyl, unsubstituted or substituted C3-10 aryl, unsubstituted or substituted 5- to 10-membered heteroaryl, unsubstituted or substituted 3- to 10-membered heterocyclyl; wherein Ra, Rb and Rc are each independently selected from hydrogen, unsubstituted or substituted C1-6 haloalkyl, unsubstituted or substituted C1-6 alkyl, unsubstituted or substituted C3-6 cycloalkyl, unsubstituted or substituted C2-6 alkenyl, unsubstituted or substituted C2-6 alkynyl, unsubstituted or substituted C6-10 aryl, unsubstituted or substituted 5- to 10-membered heteroaryl, unsubstituted or substituted aryl-C1-4 alkyl, and unsubstituted or substituted aryloy-C1-4 alkyl; or two of Ra, Rb together or Ra and Rc together with the atom(s) to which they are attached, may form an unsubstituted or substituted 5-, 6- or 7-membered ring.